Inventor
MICHAELIDES MICHAEL R
US36 patents
⚠️ This page may combine multiple inventors who share the name “MICHAELIDES MICHAEL R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
18 patentsUS7297709B2Nov 20, 2007
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
ABBOTT LAB92 citations98
US6294573B1Sep 25, 2001
Reverse hydroxamate inhibitors of matrix metalloproteinases
ABBOTT LAB131 citations97
US6235786B1May 22, 2001
Reverse hydroxamate inhibitors of matrix metalloproteinases
ABBOTT LAB103 citations96
US5952320ASep 14, 1999
Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion
ABBOTT LAB34 citations92
US5597832AJan 28, 1997
Tetracyclic compounds as dopamine agonists
ABBOTT LAB34 citations92
US5811425ASep 22, 1998
Heterocyclic compounds as COX-2 inhibitors
ABBOTT LAB44 citations90
US4994486AFeb 19, 1991
Dopaminergic compounds
ABBOTT LAB23 citations90
US7829570B2Nov 9, 2010
Substituted 4-amino isoxazolo[5,4-d]pyrimidines as kinase inhibitors
ABBOTT LAB14 citations83
US7812166B2Oct 12, 2010
Kinase inhibitors
ABBOTT LAB15 citations83
US7202363B2Apr 10, 2007
Thienopyridine and furopyridine kinase inhibitors
ABBOTT LAB12 citations82
US7598283B2Oct 6, 2009
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
ABBOTT LAB5 citations73
US5985911ANov 16, 1999
C-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretion
ABBOTT LAB10 citations72
US6288261B1Sep 11, 2001
Inhibitors of matrix metalloproteinases
ABBOTT LAB10 citations71
US7560552B2Jul 14, 2009
Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
ABBOTT LAB3 citations62
US7737160B2Jun 15, 2010
Thienopyridine and furopyridine kinase inhibitors
ABBOTT LAB2 citations60
US7468371B2Dec 23, 2008
Tricyclic pyrazole kinase inhibitors
ABBOTT LAB4 citations60
US7795248B2Sep 14, 2010
Substituted 7,8-dihydro-1H-pyrimido[4,5-B][1,4]diazepin-4-amines are novel kinase inhibitors
ABBOTT LAB0 citations38
US5659037AAug 19, 1997
Process for preparing chiral tetracyclic dopaminergic compounds
ABBOTT LAB0 citations34
ABBVIE INC
7 patentsUS9284272B2Mar 15, 2016
Inhibitors of histone methyltransferase G9a
ABBVIE INC7 citations79
US9187472B2Nov 17, 2015
NAMPT inhibitors
ABBVIE INC5 citations70
US9051327B2Jun 9, 2015
Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases
ABBVIE INC2 citations61
US9193723B2Nov 24, 2015
NAMPT inhibitors
ABBVIE INC2 citations60
US8940778B2Jan 27, 2015
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
ABBVIE INC0 citations51
US8642776B2Feb 4, 2014
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
ABBVIE INC0 citations51
US9957274B2May 1, 2018
Indane inhibitors of EED and methods of their use
ABBVIE INC0 citations38
MICHAELIDES MICHAEL R
5 patentsUS8436179B2May 7, 2013
Kinase inhibitor with improved solubility profile
MICHAELIDES MICHAEL R0 citations50
US8124759B2Feb 28, 2012
Inhibitors of protein kinases
MICHAELIDES MICHAEL R0 citations50
US8722890B2May 13, 2014
Thieno[3,2-C]pyridine kinase inhibitors with improved CYP safety profile
MICHAELIDES MICHAEL R1 citations48
US8293738B2Oct 23, 2012
Indazole inhibitors of kinase
MICHAELIDES MICHAEL R0 citations39
US8691810B2Apr 8, 2014
Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases
MICHAELIDES MICHAEL R0 citations38